Order of the Court (Eighth Chamber) of 14 May 2012
Sepracor Pharmaceuticals (Ireland) Ltd v European Commission
Appeal — Regulation (EC) No 726/2004 — Medicinal products for human use — Active substance ‘eszopiclone’ — Marketing authorisation — Procedure — Statement of position by the Commission — Status of ‘new active substance’ — Concept of ‘actionable measure’
Case C‑477/11 P
published in the electronic Reports of Cases (Court Reports - general - 'Information on unpublished decisions' section)